In this paper, we report the effects of partial cN-II silencing in a model of lung cancer (NCI-H292), demonstrating that cN-II silencing increases oxidative metabolism and decreases proliferation by activating both p53 and AMPK. This evidence concerns the gene NT5C2 and lung cancer.